1. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial. Issue 10 (October 2021) Authors: Ruckwardt, Tracy J; Morabito, Kaitlyn M; Phung, Emily; Crank, Michelle C; Costner, Pamela J; Holman, LaSonji A; Chang, Lauren A; Hickman, Somia P; Berkowitz, Nina M; Gordon, Ingelise J; Yamshchikov, Galina V; Gaudinski, Martin R; Lin, Bob; Bailer, Robert; Chen, Man; Ortega-Villa, Ana M; Nguyen, T... Journal: Lancet Issue: Volume 9:Issue 10(2021) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗